Two Baxter Facilities Recognized With Shingo Prize for Excellence in Manufacturing

Baxter's North Cove Facility Becomes First Two-Time Winner of Shingo Prize

13-Feb-2007 - Two Baxter International Inc. manufacturing facilities are being recognized with the 2007 Shingo Prize for Excellence in Manufacturing. Baxter's North Cove facility in Marion, North Carolina and Cuernavaca facility in Morelos, Mexico are being honored for their achievements in driving higher ...

Baiyunshan and Baxter plan to form Parenteral Nutrition Joint Venture in China

16-Nov-2006 - Baxter International Inc. and Guangzhou Baiyunshan Pharmaceutical Co. Ltd. announced plans to establish a joint venture to produce and sell parenteral nutrition products in China. Under the terms of a framework agreement, subsidiaries of the two companies will form a 50/50 joint venture during ...

Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine

28-Feb-2006 - Baxter International Inc. announced that its European subsidiary has received a contract from the National Health Service (NHS) in the United Kingdom to produce a stockpile of two million doses of candidate H5N1 influenza vaccine based on an avian strain. Under the agreement, Baxter will complete ...

Acambis completes delivery of 500,000 doses of MVA3000 smallpox vaccine to US Government

06-Dec-2005 - Acambis plc announced that it has completed the delivery under contract terms of 500,000 doses of its investigational MVA attenuated smallpox vaccine, MVA3000, to the National Institute of Allergy and Infectious Diseases ("NIAID"), part of the US National Institutes of Health. The delivery ...